Cargando…

Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey

The prevalence of β-thalassemia (β-thal) carriers in Turkey varies according to region but in general it is 2.0%. Çanakkale is a city in the Aegean region of Turkey but no study about β-thal frequency in Çanakkale has been published to date. In this study, we aimed to investigate the frequency of β-...

Descripción completa

Detalles Bibliográficos
Autores principales: Uludağ, A, Uysal, A, Ertekin, YH, Tekin, M, Kütük, B, Silan, F, Özdemir, Ö
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026277/
https://www.ncbi.nlm.nih.gov/pubmed/27785405
http://dx.doi.org/10.1515/bjmg-2016-0004
_version_ 1782454104797216768
author Uludağ, A
Uysal, A
Uludağ, A
Ertekin, YH
Tekin, M
Kütük, B
Silan, F
Özdemir, Ö
author_facet Uludağ, A
Uysal, A
Uludağ, A
Ertekin, YH
Tekin, M
Kütük, B
Silan, F
Özdemir, Ö
author_sort Uludağ, A
collection PubMed
description The prevalence of β-thalassemia (β-thal) carriers in Turkey varies according to region but in general it is 2.0%. Çanakkale is a city in the Aegean region of Turkey but no study about β-thal frequency in Çanakkale has been published to date. In this study, we aimed to investigate the frequency of β-thal mutations in this province. A total of 4452 couples (8904 individuals) applied for premarital thalassemia scans at the Çanakkale State Health Directorate Laboratory between January 2008 and June 2012 and scanning was done with high performance liquid chromatography (HPLC). Of 125 β-thal carriers seen at the Medical Genetics Clinic, Çanakkale Onsekiz Mart University, Çanakkale, Turkey, for genetic counseling, 46 participated in the study. The remaining 79 patients could not be reached. The prevalence for β-thal carriers in Çanakkale was identified as 1.4% (125/8904). One couple were both β-thal carriers. β-Globin gene analysis of 46 carriers found the total frequency of the three most common mutations was 45.6%. These mutations were found to be HBB: c.93-21G>A [IVS-I-110 (G>A)], 26.08% (12/46); HBB: c.17_ 18delCT [codon 5 (‒CT)], 10.85% (5/46); HBB: c.20delA [codon 6 (‒A)] 8.69% (4/46). This is the first report on the frequency and mutation profiles of β-thal for Çanakkale. The incidence of β-thal carriers in Çanakkale is below the average for Turkey. The most frequently observed mutation profile and rate of β-thal in our region is different from the other regions of Turkey.
format Online
Article
Text
id pubmed-5026277
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-50262772016-10-26 Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey Uludağ, A Uysal, A Uludağ, A Ertekin, YH Tekin, M Kütük, B Silan, F Özdemir, Ö Balkan J Med Genet Original Article The prevalence of β-thalassemia (β-thal) carriers in Turkey varies according to region but in general it is 2.0%. Çanakkale is a city in the Aegean region of Turkey but no study about β-thal frequency in Çanakkale has been published to date. In this study, we aimed to investigate the frequency of β-thal mutations in this province. A total of 4452 couples (8904 individuals) applied for premarital thalassemia scans at the Çanakkale State Health Directorate Laboratory between January 2008 and June 2012 and scanning was done with high performance liquid chromatography (HPLC). Of 125 β-thal carriers seen at the Medical Genetics Clinic, Çanakkale Onsekiz Mart University, Çanakkale, Turkey, for genetic counseling, 46 participated in the study. The remaining 79 patients could not be reached. The prevalence for β-thal carriers in Çanakkale was identified as 1.4% (125/8904). One couple were both β-thal carriers. β-Globin gene analysis of 46 carriers found the total frequency of the three most common mutations was 45.6%. These mutations were found to be HBB: c.93-21G>A [IVS-I-110 (G>A)], 26.08% (12/46); HBB: c.17_ 18delCT [codon 5 (‒CT)], 10.85% (5/46); HBB: c.20delA [codon 6 (‒A)] 8.69% (4/46). This is the first report on the frequency and mutation profiles of β-thal for Çanakkale. The incidence of β-thal carriers in Çanakkale is below the average for Turkey. The most frequently observed mutation profile and rate of β-thal in our region is different from the other regions of Turkey. De Gruyter 2016-08-02 /pmc/articles/PMC5026277/ /pubmed/27785405 http://dx.doi.org/10.1515/bjmg-2016-0004 Text en © 2016 Walter de Gruyter GmbH, Berlin/Boston
spellingShingle Original Article
Uludağ, A
Uysal, A
Uludağ, A
Ertekin, YH
Tekin, M
Kütük, B
Silan, F
Özdemir, Ö
Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey
title Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey
title_full Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey
title_fullStr Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey
title_full_unstemmed Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey
title_short Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey
title_sort prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in çanakkale province, turkey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026277/
https://www.ncbi.nlm.nih.gov/pubmed/27785405
http://dx.doi.org/10.1515/bjmg-2016-0004
work_keys_str_mv AT uludaga prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey
AT uysala prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey
AT uludaga prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey
AT ertekinyh prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey
AT tekinm prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey
AT kutukb prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey
AT silanf prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey
AT ozdemiro prevalenceandmutationsofbthalassemiatraitandabnormalhemoglobinsinpremaritalscreeningincanakkaleprovinceturkey